Valuation: Dr. Reddy's Laboratories Limited

Market Cap 967B 10.09B 8.74B 8.25B 7.49B 14.04B 14.14B 98.54B 37.97B 491B 37.9B 37.06B 1,560B P/E 2027 *
25.7x
P/E 2028 * 20x
Enterprise Value 936B 9.76B 8.46B 7.98B 7.24B 13.58B 13.68B 95.32B 36.73B 475B 36.66B 35.85B 1,509B EV / Sales 2027 *
2.66x
EV / Sales 2028 * 2.33x
Free-Float
69.71%
Yield 2027 *
0.65%
Yield 2028 * 0.72%
1 week+1.26%
Current month+0.96%
1 month-3.28%
3 months-8.66%
6 months-12.07%
Current year-8.33%
1 week 1,130
Extreme 1130
1,182
1 month 1,130
Extreme 1130
1,208.1
3 years 1,020
Extreme 1020
1,421.49
5 years 730.8
Extreme 730.8
1,421.49
10 years 374.59
Extreme 374.59
1,421.49
Manager TitleAgeSince
Chief Executive Officer 59 2019-06-30
Director of Finance/CFO - 2024-07-31
Chief Operating Officer - -
Director TitleAgeSince
Chairman 58 2014-05-12
Chairman 65 2013-04-01
Director/Board Member 65 2018-10-24
Change 5-day change 1-year change 3-year change Capi.($)
+1.97%+1.26%-10.56%+3.81% 10.12B
+2.02%-0.96%+50.69%+92.40% 994B
+0.28%-3.24%+49.57%+62.65% 640B
+1.81%+2.07%+19.89%+70.38% 454B
+5.00%+2.21%+36.64%+39.24% 337B
+1.68%-9.20%+15.25%+24.87% 261B
+3.81%+0.93%+3.05%+12.39% 246B
+1.10%-12.75%+38.03%+45.44% 204B
+1.43%-6.21%-19.49%-58.94% 190B
+1.87%-3.04%+27.81%+89.26% 178B
Average +2.00%-4.63%+21.09%+38.15% 389.42B
Weighted average by Cap. +1.60%-3.19%+33.33%+57.12%

Financials

2027 *2028 *
Net sales 352B 3.67B 3.18B 3B 2.72B 5.11B 5.15B 35.85B 13.81B 178B 13.79B 13.48B 567B 393B 4.1B 3.55B 3.35B 3.04B 5.7B 5.74B 40.01B 15.42B 199B 15.39B 15.05B 633B
Net income 37.21B 388M 336M 317M 288M 540M 544M 3.79B 1.46B 18.88B 1.46B 1.43B 60.01B 48.98B 511M 443M 418M 379M 711M 716M 4.99B 1.92B 24.85B 1.92B 1.88B 78.99B
Net Debt -31.58B -330M -286M -269M -244M -459M -462M -3.22B -1.24B -16.02B -1.24B -1.21B -50.93B -51.62B -539M -467M -440M -400M -749M -755M -5.26B -2.03B -26.19B -2.02B -1.98B -83.25B
Logo Dr. Reddy's Laboratories Limited
Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.
Employees
-
Date Price Change
26-09-11 ₹1,165.50 +1.97%
26-09-10 ₹1,143.00 -0.17%
26-09-09 ₹1,145.00 -0.52%
26-09-08 ₹1,151.00 +0.59%
26-09-07 ₹1,144.20 -0.59%
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
39
Last Close Price
1,161.00INR
Average target price
1,265.77INR
Spread / Average Target
+9.02%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!